Table of Contents

• R Gougeon,
• K Styhler,
• J A Morais,
• P J Jones,
• and E B Marliss

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.

• V Vuksan,
• J L Sievenpiper,
• R Owen,
• J A Swilley,
• P Spadafora,
• D J Jenkins,
• E Vidgen,
• F Brighenti,
• R G Josse,
• L A Leiter,
• Z Xu,
• and R Novokmet

Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.

• R G Moses,
• S J Knights,
• E M Lucas,
• M Moses,
• K G Russell,
• K J Coleman,
• and W S Davis

Gestational diabetes: is a higher cesarean section rate inevitable?

• M Wei,
• L W Gibbons,
• T L Mitchell,
• J B Kampert,
• and S N Blair

Alcohol intake and incidence of type 2 diabetes in men.

• T L Gary,
• R M Crum,
• L Cooper-Patrick,
• D Ford,
• and F L Brancati

Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.

• L Tarnow,
• P Rossing,
• F S Nielsen,
• J A Fagerudd,
• O Poirier,
• and H H Parving

Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.

• J E Shaw,
• P Z Zimmet,
• A M Hodge,
• M de Courten,
• G K Dowse,
• P Chitson,
• J Tuomilehto,
• and K G Alberti

Impaired fasting glucose: how low should it go?

• F de Vegt,
• J M Dekker,
• C D Stehouwer,
• G Nijpels,
• L M Bouter,
• and R J Heine

Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.

• M Muggeo,
• G Zoppini,
• E Bonora,
• E Brun,
• R C Bonadonna,
• P Moghetti,
• and G Verlato

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.

• T S Larson,
• N Santanello,
• S Shahinfar,
• P C O'Brien,
• P J Palumbo,
• L J Melton, 3rd,
• and C L Leibson

Trends in persistent proteinuria in adult-onset diabetes: a population-based study.

• E Bonora,
• G Targher,
• M Alberiche,
• R C Bonadonna,
• F Saggiani,
• M B Zenere,
• T Monauni,
• and M Muggeo

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

• J P Frias,
• J G Yu,
• Y T Kruszynska,
• and J M Olefsky

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

• J Rissanen,
• A Markkanen,
• P Kärkkäinen,
• J Pihlajamäki,
• P Kekäläinen,
• L Mykkänen,
• J Kuusisto,
• P Karhapää,
• L Niskanen,
• and M Laakso

Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.

• G B Phillips,
• C H Tuck,
• T Y Jing,
• B Boden-Albala,
• I F Lin,
• N Dahodwala,
• and R L Sacco

Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.

• R Burgos,
• C Mateo,
• A Cantón,
• C Hernández,
• J Mesa,
• and R Simó

Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.

• C Pavía,
• I Ferrer,
• C Valls,
• R Artuch,
• C Colomé,
• and M A Vilaseca

Total homocysteine in patients with type 1 diabetes.

• A Gürlek,
• M Bayraktar,
• and S Kirazli

Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

Smoking and diabetes: American Diabetes Association.

• S A Smith and
• G A Poland

Use of influenza and pneumococcal vaccines in people with diabetes.

Immunization and the prevention of influenza and pneumococcal disease in people with diabetes: American Diabetes Association.

• R P Robertson,
• C Davis,
• J Larsen,
• R Stratta,
• and D E Sutherland

Pancreas and islet transplantation for patients with diabetes.

Pancreas transplantation for patients with type 1 diabetes: American Diabetes Association.

• Z T Bloomgarden

American Diabetes Association Annual Meeting, 1999: diabetes and obesity.

• T S Harwell,
• J G Smilie,
• J M McDowall,
• S D Helgerson,
• and D Gohdes

Diabetes screening practices among individuals aged 45 years and older.

• R W Holl,
• C Buck,
• C Babka,
• A Wolf,
• and A Thon

HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.

• A R Shuldiner,
• W Nguyen,
• W H Kao,
• B A Beamer,
• R E Andersen,
• R Pratley,
• and F L Brancati

Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.

• A Taniguchi,
• M Fukushima,
• M Sakai,
• I Nagata,
• K Doi,
• S Nagasaka,
• K Tokuyama,
• and Y Nakai

Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.

• D S Bell and
• F Ovalle

Late-onset troglitazone-induced hepatic dysfunction.

• H Noto,
• K Tsukamoto,
• and S Kimura

Glyburide-induced hemolysis in myelodysplastic syndrome.

• O Pecchio,
• S Maule,
• M Migliardi,
• M Trento,
• and M Veglio

Effects of exposure at an altitude of 3,000 m on performance of glucose meters.

• Y Murase,
• T Wakasugi,
• K Yagi,
• and H Mabuchi

Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.